The rabies vaccine is
an important vaccine used to protect against rabies, a deadly disease that
kills animals in many countries. There are many different rabies vaccines on
the market that both effective and safe. They may be used as a preventative
measure to prevent rabies in time of exposure, prior to, and after, contact
with the rabies-causing virus, which is most commonly acquired by a dog bite or
other animal bite. Rabies is one of the most severe zoonotic diseases that can
infect humans through bites of animals such as raccoons, dogs, cats, bats, and
foxes.
Global
Rabies Vaccines Market- Drivers
Key players are focused on research
and development strategies which are expected to drive the global rabiesvaccine market growth during the forecast period. For instance, in 2017, CPL
Laboratories (India), a joint venture biotechnology company established in 2009
by Novavax Inc., USA and Cadila Pharmaceuticals Limited, stated that Nano-
particle vaccine of baculvirous-derived glycoprotein, a four dose regime
vaccine is in phase-3 human trial, and is expected to be approved by 2021.
Comments
Post a Comment